Carbon nanotubes as vaccine scaffolds
- PMID: 23899863
- PMCID: PMC3855883
- DOI: 10.1016/j.addr.2013.07.013
Carbon nanotubes as vaccine scaffolds
Abstract
Carbon nanotubes display characteristics that are potentially useful in their development as scaffolds for vaccine compositions. These features include stability in vivo, lack of intrinsic immunogenicity, low toxicity, and the ability to be appended with multiple copies of antigens. In addition, the particulate nature of carbon nanotubes and their unusual properties of rapid entry into antigen-presenting cells, such as dendritic cells, make them especially useful as carriers of antigens. Early attempts demonstrating carbon nanotube-based vaccines can be used in both infectious disease settings and cancer are promising.
Keywords: Carbon nanotubes; adjuvants; antigen presenting cells; vaccines.
© 2013.
Similar articles
-
Lentinan-Modified Carbon Nanotubes as an Antigen Delivery System Modulate Immune Response in Vitro and in Vivo.ACS Appl Mater Interfaces. 2016 Aug 3;8(30):19276-83. doi: 10.1021/acsami.6b04591. Epub 2016 Jul 22. ACS Appl Mater Interfaces. 2016. PMID: 27411887
-
Vaccines that facilitate antigen entry into dendritic cells.Immunol Cell Biol. 2004 Oct;82(5):506-16. doi: 10.1111/j.0818-9641.2004.01271.x. Immunol Cell Biol. 2004. PMID: 15479436 Review.
-
Induction and direction of immune responses by vaccine adjuvants.Crit Rev Immunol. 2001;21(1-3):75-85. Crit Rev Immunol. 2001. PMID: 11642615 Review.
-
Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases.Int J Infect Dis. 2014 Feb;19:1-5. doi: 10.1016/j.ijid.2013.09.023. Epub 2013 Nov 8. Int J Infect Dis. 2014. PMID: 24216295 Review.
-
Targeting human dendritic cells in situ to improve vaccines.Immunol Lett. 2014 Nov;162(1 Pt A):59-67. doi: 10.1016/j.imlet.2014.07.004. Epub 2014 Jul 27. Immunol Lett. 2014. PMID: 25072116 Free PMC article. Review.
Cited by
-
Non-covalent and reversible functionalization of carbon nanotubes.Beilstein J Nanotechnol. 2014 Sep 30;5:1675-90. doi: 10.3762/bjnano.5.178. eCollection 2014. Beilstein J Nanotechnol. 2014. PMID: 25383279 Free PMC article. Review.
-
Free-standing alumina nanobottles and nanotubes pre-integrated into nanoporous alumina membranes.Sci Technol Adv Mater. 2014 Jul 18;15(4):045004. doi: 10.1088/1468-6996/15/4/045004. eCollection 2014 Aug. Sci Technol Adv Mater. 2014. PMID: 27877705 Free PMC article.
-
Nanomaterial Adjuvants for Veterinary Vaccines: Mechanisms and Applications.Research (Wash D C). 2025 Jul 8;8:0761. doi: 10.34133/research.0761. eCollection 2025. Research (Wash D C). 2025. PMID: 40636132 Free PMC article. Review.
-
Poly-dispersed Acid-Functionalized Single-Walled Carbon Nanotubes (AF-SWCNTs) Are Potent Inhibitor of BCG Induced Inflammatory Response in Macrophages.Inflammation. 2021 Jun;44(3):908-922. doi: 10.1007/s10753-020-01386-8. Epub 2021 Jan 5. Inflammation. 2021. PMID: 33400104
-
Characterization of Betulinic Acid-Multiwalled Carbon Nanotubes Modified with Hydrophilic Biopolymer for Improved Biocompatibility on NIH/3T3 Cell Line.Polymers (Basel). 2021 Apr 21;13(9):1362. doi: 10.3390/polym13091362. Polymers (Basel). 2021. PMID: 33919467 Free PMC article.
References
-
- Mackall CL. Spreading the wealth: Antigen discovery in adult tumors can help hone the search for pediatric tumor antigens. J. Immunother. 2001;24:281. - PubMed
-
- Farkas AM, Finn OJ. Vaccines based on abnormal self-antigens as tumor-associated antigens: Immune regulation. Semin. Immunol. 2010;22:125. - PubMed
-
- Steinman RM, Banchereau J. Taking dendritic cells into medicine. Nature. 2007;449:419. - PubMed
-
- Melief CJM. Cancer immunotherapy by dendritic cells. Immunity. 2008;29:372. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical